PH01005185G0040's details annotation
1.Annotation
ICBR annotation: inosine-uridine preferring nucleoside hydrolase family protein, putative, expressed
Blast result AT1G05620 : 2.00E-133
Blast annotation: uridine-ribohydrolase 2
2.Location
Scaffold: PH01005185
Strand: +
| Region | Start | End |
| gene | 50855 | 57846 |
| mRNA | 50855 | 57846 |
| exon | 50855 | 51441 |
| exon | 51548 | 51607 |
| exon | 51732 | 51950 |
| exon | 52065 | 52169 |
| exon | 53660 | 53797 |
| exon | 54757 | 54861 |
| exon | 55372 | 55455 |
| exon | 55545 | 55658 |
| exon | 56015 | 56111 |
| exon | 56661 | 56768 |
| exon | 56894 | 57029 |
| exon | 57155 | 57846 |
| CDS | 51334 | 51441 |
| CDS | 51548 | 51607 |
| CDS | 51732 | 51950 |
| CDS | 52065 | 52169 |
| CDS | 53660 | 53797 |
| CDS | 54757 | 54861 |
| CDS | 55372 | 55455 |
| CDS | 55545 | 55658 |
| CDS | 56015 | 56111 |
| CDS | 56661 | 56768 |
| CDS | 56894 | 57029 |
| CDS | 57155 | 57266 |
3.Network
| Co-expression Network Category | Global Network | Conditional Network | |
| Co-expression Positive |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Co-expression Negative |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Predict protein-portein interaction | details | ||
| miRNA-targets relationship | null | ||
4.Functional module
| Method | Module ID | Function Annotation |
| coexpression network | CFinderM001480 | Steroid_biosynthesis oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor, membrane, |
5.Cis-elements
Details in 3kb promoter region
6.Expression profilings
7.Gene family
| Category | Family |
| null | null |
8.Protein domain
| Pfam Accession | Pfam Annotation | Alignment Start | Alignment Start |
| PF01156.18 | IU_nuc_hydro | 10 | 315 |
9.KEGG Pathway
| Pathway | KEGG Ortholog | Pathway ID | KO |
| null | null | null | null |
10.Gene Ontology
| GO Accession | GO Annotation |
| null | null |
Maintained by Xuelian Ma - Zhen Su's Lab - China Agricultural University
© 2017 All Rights Reserved.
© 2017 All Rights Reserved.